课题基金 / 基金详情

Development of asymmetric syntheses and valuable bioactive compounds based on alkenylphosphonates

Development of asymmetric syntheses and valuable bioactive compounds based on alkenylphosphonates
基于烯基膦酸酯的不对称合成和有价值的生物活性化合物的开发
批准号:
15590031
负责人:
IWAKI Hiroaki
金额:
$1.73万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2003
资助国家:
日本
项目状态:
已结题
起止时间:
2003 至 2005

项目摘要

项目成果

IWAKI Hiroaki的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Phosphates are vital components in our body as an intermediate of the energy storage and the intracellular signaling. Phosphonate derivatives are analogues of phosphates and can be act as agonists or antagonists of the biochemical reactions mediated by phosphates. Some of them have already been used as real drugs. On the other hand, from the synthetic organic chemistry point of view, phosphonates are versatile as substrates for an olefin forming reaction, Horner-Wadsworth-Emmons reaction, and also as synthetic intermediates of chiral phosphine ligands for the transition metal catalysis. Thus, in the study based on phosphonates, we can expect the development of the research in which both synthetic organic chemistry and biological chemistry are combined together. The purpose of this study is the creation of useful physiologically active compounds based on phosphonates using synthetic technology we have developed.In the present study, I focused on the development of immunosuppressive agent. An immunosuppressant FTY-720 is known to be activated by phosphorylation in one of its hydroxyl groups. The activated FTY-720 binds to sphingosine-1-phosphate receptor and cause the homing of the lymphocytes to lymph node. Thereby, I expected the increase of the activity with the application of phosphorilated FTY-720. The phosphonates, however, likely to be hydrolysed in the body. It is, therefore, we synthesized cyclic phosphates as a stable phosphorilated derivatives of FTY-720 in this study. Cyclic phosphates are not only stable but also non-asymmetric compounds which is advantageous for the further development for drugs. We also synthesized phosphonate derivatives of FTY-720. The immunosuppressive activity of the derivatives is being evaluated.
期刊论文(42)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/j.bmc.2004.06.020
发表时间: 2004-08-15
期刊: BIOORGANIC & MEDICINAL CHEMISTRY
影响因子: 3.5
作者: [Maeda, T, Nagaoka, Y, Uesato, S]
通讯作者: Uesato, S
Y.Nagaoka: "Ion channel properties of peptaibols and their derivatives"Membrane. 28・2. 61-69 (2003)
Y.Nagaoka:“肽醇及其衍生物的离子通道特性”28・2(2003)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Effect of 3-O-Octanoyl-(+)-catechin on the Responses of GABAA Receptors and Na+/Glucose Cotransporters Expressed in Xenopus Oocytes and on the Oocyte Membrane Potential.
3-O-辛酰基-( )-儿茶素对非洲爪蟾卵母细胞中表达的 GABAA 受体和 Na/葡萄糖协同转运蛋白的反应以及卵母细胞膜电位的影响。
DOI: --
发表时间: 2005
期刊: Journal of Agricultural Food Chemistry 53
影响因子: --
作者: [H.Aoshima, Y.Okita, S.J.Hossain, K.Fukue, M.Mito, Y.Orihara, T.Yokoyama, M.Yamada, A.Kumagai, Y.Nagaoka, S.Uesato, Y.Hara]
通讯作者: Y.Hara
K.Nishimura, H.Tsubouchi, M.Ono, T.Hayama, Y.Nagaoka, K.Tomioka: "Asummetric Michael-aldol tandem cyclization of ω-oxo-a, b-unsaturated esters with 10-mercaptoisoborneol methyl ether"Tetrahedron Lett.. 44. 2323-2326 (2003)
K.Nishimura、H.Tsubouchi、M.Ono、T.Hayama、Y.Nagaoka、K.Tomioka:“ω-氧代-a、b-不饱和酯与 10-巯基异冰片甲基醚的 Asummetric Michael-aldol 串联环化”莱特.. 44. 2323-2326 (2003)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
24
    Genetic analysis of chemotactic receptors in bacteria
    • 批准号:
      22780077
    • 项目类别:
      Grant-in-Aid for Young Scientists (B)
    • 资助金额:
      $1.91万
    • 财政年份:
      2010
    • 负责人:
      IWAKI Hiroaki
    • 依托单位:
    海外基金